Retatrutide

Identity

Retatrutide (development code LY3437943) is an investigational peptide that acts as an agonist at three receptors: GIP, GLP-1 and glucagon. It is under clinical investigation and has not been approved as a medicine.

Structure

Molecular formula C221H342N46O68, molar mass 4731.3 g/mol. CAS 2381089-83-2.

Regulatory status

Investigational. Not authorised as a medicinal product in the EU or the US. Check the current status before publishing, as it may change.

Handling

White lyophilised powder. Store at 2 to 8 °C (refrigerated), protected from light. Supplied with bacteriostatic water.